- Home
- NBY vs MULN Comparison
NBY vs MULN Comparison
Compare NBY & MULN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- MULN
- Stock Information
- Founded
- NBY 2000
- MULN 2014
- Country
- NBY United States
- MULN United States
- Employees
- NBY N/A
- MULN N/A
- Industry
- NBY
- MULN Auto Manufacturing
- Sector
- NBY
- MULN Consumer Discretionary
- Exchange
- NBY Nasdaq
- MULN Nasdaq
- Market Cap
- NBY 3.4M
- MULN 6.5M
- IPO Year
- NBY 2007
- MULN N/A
- Fundamental
- Price
- NBY $0.69
- MULN $0.15
- Analyst Decision
- NBY Strong Buy
- MULN
- Analyst Count
- NBY 1
- MULN 0
- Target Price
- NBY $0.85
- MULN N/A
- AVG Volume (30 Days)
- NBY 23.6K
- MULN 39.4M
- Earning Date
- NBY 08-12-2025
- MULN 08-11-2025
- Dividend Yield
- NBY N/A
- MULN N/A
- EPS Growth
- NBY N/A
- MULN N/A
- EPS
- NBY 0.57
- MULN N/A
- Revenue
- NBY $9,781,000.00
- MULN $8,931,612.00
- Revenue This Year
- NBY $23.91
- MULN N/A
- Revenue Next Year
- NBY $32.05
- MULN N/A
- P/E Ratio
- NBY $1.51
- MULN N/A
- Revenue Growth
- NBY 20.52
- MULN 2136.62
- 52 Week Low
- NBY $0.36
- MULN $0.14
- 52 Week High
- NBY $2.45
- MULN $133,800,000.00
- Technical
- Relative Strength Index (RSI)
- NBY 68.26
- MULN 18.78
- Support Level
- NBY $0.60
- MULN $0.15
- Resistance Level
- NBY $0.70
- MULN $0.35
- Average True Range (ATR)
- NBY 0.04
- MULN 0.15
- MACD
- NBY 0.01
- MULN 62.47
- Stochastic Oscillator
- NBY 93.85
- MULN 0.17
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About MULN Mullen Automotive Inc.
Mullen Automotive Inc is engaged in manufacturing electric vehicles and building energy solutions. Its portfolio of vehicles is predominantly comprised of commercial trucks and other electric vehicles and includes; Mullen Class 1 Cargo Van, Mullen Three, Bollinger B4 Chassis Cab, and Mullen I-GO. The company's operating segments are Bollinger which derives maximum revenue, and Mullen Commercial.